Hide Board Information

Show Board Information

Tanke Incorporated TNKE

Board Mod: StockMasterTalk

Asst Mods:

Last Post: 04/16/2018 2:35:09 PM

Board Marks: 3

Posts Today: 0

Board Views Today: 12

Tanke Incorporated (OTCMRKTS: TNKE) Stock Message Board

1. TNKE Company Profile

    

2. TNKE Time & Sales

    

3. TNKE Recent News

    

4. TNKE Filings

    

5. TNKE Financials

    

6. TNKE Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

7	TNKE $.42 Tanke is a diversified holding company	Roger Wilco	02/24/2014 8:54:57 AM
6	pm volume! on watch here	KaiserSose	02/24/2014 8:39:22 AM
5	O/S: 287,393,802 / Float:	KaiserSose	02/24/2014 8:20:47 AM
4	####	KaiserSose	02/24/2014 8:19:07 AM
3	##### recent news/filings ~ source:	KaiserSose	02/24/2014 8:16:49 AM
2	Investor Summary	KaiserSose	02/24/2014 7:52:43 AM
1	$TNKE Pr breakout $0.20 called 2/18/14 PYCKtrtadr	PoemStone	02/22/2014 8:01:32 PM

Newer

Recent Articles

• Surging Growth in Salicylic Acid Market Expected by 2031
• Trigger Sprayer Market Growth: Key Factors and Future Outlook
• George Clinical Appoints Tony Proctor as New CFO Enhancing Strategy
• George Clinical Appoints Tony Proctor as CFO to Drive Growth
• Analysis of Current Water Technologies' Q3 2024 Results
• CNOOC Limited Launches New Huizhou 26-6 Oilfield Project
• Trip.com Group's Eco-Friendly Country Retreats Shine in UN Report
• AWH Launches Bell Review to Overhaul WHO's Framework
• Experience the Art of Ninjutsu at Ekoin Temple
• Itron Collaborates with Jemena for Rooftop Solar Management
• Calibre Mining Clarifies Position on Condor Gold Developments
• ROLLER Achieves Recognition for Outstanding Global Growth
• Investors of Warner Bros. Discovery Have Class Action Options
• Humacyte, Inc. Investors Can Lead Class Action Against Company
• Investors Alert: Join the Class Action Against Wolfspeed, Inc.
• Legal Action for Dentsply Sirona Inc. Investors Explained
• Investors Invited to Explore Class Action against Rentokil Initial
• Stellantis Board Announces Leadership Transition and Future Plans
• NetApp Unveils New Integrated AWS Outposts Storage Solution
• Lion Electric Adapts to Challenges with Strategic Amendments
• Lead Plaintiffs Sought in Match Group, Inc. Securities Case
• Uncovering Truth: The Future of American Journalism
• Revolutionizing MRI Scans with Sonic DL for 3D Imaging
• Understanding Black Friday Traffic Trends and Retail Shifts
• Innovative AI Developments in Ultrasound by Siemens and DeepHealth
• Varex Unveils Next-Gen Radiography Detectors for Healthcare
• Understanding the Humacyte Securities Class Action Opportunity
• Merus Highlights Promising Findings on Petosemtamab for Cancer
• Discover Unique (RED) Gifts That Make a Difference Today
• Philips Installs Advanced AI in CT 5300 to Enhance Diagnostics
• Bayer Highlights Innovations in Radiology for Healthcare Advancement
• GPM Investments' Holiday Campaign Boosts MDA Support Nationwide
• Philips Launches AI Innovations at RSNA 2024 for Better Healthcare
• Maverick Medical AI Enhances Coding with RadNet Partnership
• GE HealthCare Unveils Innovative AI Solutions for Better Healthcare
• Investors' Alert: Join the Lilium N.V. Securities Class Action
• iMerit Launches ANCOR: Transforming Radiology Image Annotation
• Fovia Ai to Unveil Innovative aiCockpit at RSNA 2024
• Discover Why Winter is Prime for Hair Removal Devices
• DeepHealth Partners with CARPL.ai for Revolutionary AI Control in Radiology
• Integrating Ancient Wisdom and Modern Technology for Wellness
• How Rad AI Reporting is Transforming Radiology Practices
• Themis Introduces Tathabbat, Advancing France's Financial Security
• Experience the Revitalizing Journey through Green Agriculture
• NIO Inc. Celebrates Growth with November Delivery Results
• XPENG Achieves Record Deliveries and Expands in Global Markets
• ZEEKR Reports Striking Growth in November Vehicle Deliveries
• Mondee Holdings Faces Nasdaq Delisting, Focuses on Future Growth
• Devin Nunes Expresses Support for Kash Patel as FBI Director
• Investors Urged to Act as Edwards Lifesciences Faces Legal Scrutiny